Skip to main content

Table 1 Patients characteristics according to diagnosis and treatment groups

From: Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors

 Entire group, N = 160 (%)BS, n = 54 (%)STS, n = 106 (%)P-valueSRT, n = 64 (%)MMT, n = 96 (%)P-value
Median age, years (range)55 (19–86)39 (19–80)59 (19–86)< 0.00166 (28–86)46 (19–78)<0.001
Gender0.09  0.94
 Female74 (46)30 (56)44 (41) 30 (47)44 (46) 
 Male86 (54)24 (44)62 (59) 34 (53)52 (54) 
Median time since diagnosis, years (range)6 (0–31)5 (1–22)6 (1–31)0.114 (1–19)6 (1–31)0.07
Time since diagnosis, years0.80  0.02
 <568 (43)22 (41)46 (43) 34 (53)34 (35) 
 ≥592 (57)32 (59)60 (57) 30 (47)62 (65) 
Treatment group< 0.001   
 SRT64 (40)9 (17)55 (52)    
 MMT96 (60)45 (83)51 (48)    
  1. Italic values indicate significance of P-value (P < 0.05)
  2. BS bone sarcoma, STS soft tissue sarcoma, SRT surgery and or radiotherapy group, MMT multimodal treatment group